Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer

Abstract

Chemoprevention has been widely explored as a promising strategy for controlling the incidence of lung cancer, the leading cause of cancer-related death. To maximize the benefit of lung cancer chemoprevention, it is important to identify individuals at high risk for the disease. The genetic background has been shown to play an important role in one's risk of developing lung cancer. We report here the identification of a polymorphic tandem repeats minisatellite (termed MNS16A) in the downstream region of the human telomerase gene. This minisatellite is located upstream of an antisense transcript from the human telomerase gene locus and was demonstrated to have promoter activity. The promoter activity was significantly lower in the construct containing the shorter repeats, suggesting that the MNS16A variant may have a relevance of functionality. To explore the role of this novel polymorphism in lung cancer, we conducted a pilot hospital-based case–control study by identifying the MNS16A genotype with genomic DNA from 53 lung cancer patients and 72 cancer-free controls. We found four different alleles and classified them as shorter (S) or longer (L) on the functional basis of the length of the repeats in the controls. The MNS16A genotype distributions of the SS, SL, and LL genotypes were 11, 32, and 57%, respectively, in the cases, and 14, 40, and 46%, respectively, in the controls. Compared with the SS+SL genotype, the LL genotype was associated with greater than twofold increased risk of lung cancer (odds ratio=2.18; 95% confidence interval=0.92, 5.20) after adjustment for age, sex, ethnicity, and smoking status, suggesting a potential role of MNS16A in lung cancer susceptibility. Larger studies are needed to verify our findings.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Albanell J, Lonardo F, Rusch V, Engelhardt M, Langenfeld J, Han W, Klimstra D, Venkatraman E, Moore MA and Dmitrovsky E . (1997). J. Natl. Cancer Inst., 89, 1609–1615.

  • Bouchardy C, Benhamou S, Jourenkova N, Dayer P and Hirvonen A . (2001). Lung Cancer, 32, 109–112.

  • Bryce LA, Morrison N, Hoare SF, Muir S and Keith WN . (2000). Neoplasia, 2, 197–201.

  • Dhaene K, Van Marck E and Parwaresch R . (2000). Virchows Arch., 437, 1–16.

  • Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B . (1995). Science, 269, 1236–1241.

  • Greider CW and Blackburn EH . (1985). Cell, 43, 405–413.

  • Goode EL, Ulrich CM and Potter JD . (2002). Cancer Epidemiol. Biomarkers Prev., 11, 1513–1530.

  • Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW . (1995). J. Natl. Cancer Inst., 87, 895–902.

  • Hoff-Olsen P, Meling GI and Olaisen B . (1995). Hum. Mutat., 5, 329–332.

  • Honma M, Mizusawa H, Sasaki K, Hayashi M, Ohno T, Tanaka N and Sofuni T . (1994). Mutat. Res., 304, 167–179.

  • Imai H, Nakagama H, Komatsu K, Shiraishi T, Fukuda H, Sugimura T and Nagao M . (1997). Proc. Natl. Acad. Sci. USA, 94, 10817–10820.

  • Jeffreys AJ, Tamaki K, MacLeod A, Monckton DG, Neil DL and Armour JA . (1994). Nat. Genet., 6, 136–145.

  • Jeffreys AJ, Wilson V, Kelly R, Taylor BA and Bulfield G . (1987). Nucleic Acids Res., 15, 2823–2836.

  • American Cancer Society Inc. (2003). Cancer facts & figures, American Cancer Society: Atlanta, GA. pp. 2–5.

  • Kaplanski C, Srivatanakul P and Wild CP . (1997). Int. J. Cancer, 72, 248–254.

  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW . (1994). Science, 266, 2011–2015.

  • Ledwith BJ, Storer RD, Prahalada S, Manam S, Leander KR, van Zwieten MJ, Nichols WW and Bradley MO . (1990). Cancer Res., 50, 5245–5249.

  • Ledwith BJ, Joslyn DJ, Troilo P, Leander KR, Clair JH, Soper KA, Manam S, Prahalada S, van Zwieten MJ and Nichols WW . (1995). Carcinogenesis, 16, 1167–1172.

  • Leem S-H, Londoňo-Vallejo JA, Kim J-H, Bui H, Tubacher E, Solomon G, Park J-E, Horikawa I, Kouprina N, Barrett JC and Larionov V . (2002). Oncogene, 21, 769–777.

  • Matsumura Y and Tarin D . (1992). Cancer Res., 52, 2174–2179.

  • Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA . (1997). Cell, 90, 785–795.

  • Murnane JP, Sabatier L, Marder BA and Morgan WF . (1994). EMBO J., 13, 4953–4962.

  • Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR . (1997). Science, 277, 955–959.

  • Paquette B and Little JB . (1992). Cancer Res., 52, 5788–5793.

  • Parkin DM, Pisani P and Ferlay J . (1999). CA Cancer J. Clin., 49, 33–64.

  • Shen H, Wang L, Spitz MR, Hong WK, Mao L and Wei QY . (2002). Cancer Res., 62, 4992–4995.

  • Soria JC, Moon C, Wang L, Hittelman WN, Jang SJ, Sun S-Y, Lee JJ, Liu D, Kurie JM, Morice RC, Lee JS, Hong WK and Mao L . (2001). J. Natl. Cancer Inst., 93, 1257–1263.

  • Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Quo Z, Lei L, Mohrenweiser H and Wei Q . (2001). Cancer Res., 61, 1354–1357.

  • Szutorisz H, Palmqvist R, Roos G, Stenling R, Schorderet DF, Reddel R, Lingner J and Nabholz M . (2001). Oncogene, 20, 2600–2605.

  • Thein SL, Jeffreys AJ, Gooi HC, Cotter F, Flint J, O'Connor NT, Weatherall DJ and Wainscoat JS . (1987). Br. J. Cancer, 55, 353–356.

  • Wang L, Soria JC, Kemp BL, Liu DD, Mao L and Khuri FR . (2002). Clin. Cancer Res., 8, 2883–2889.

  • Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK and Spitz MR . (2000). J. Natl. Cancer Inst., 92, 1764–1772.

  • Wick M, Zubov D and Hagen G . (1999). Gene, 232, 97–106.

  • Xiong Y and Eickbush TH . (1990). EMBO J., 9, 3353–3362.

  • Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II, Milchgrub S, Srivastava S, Piatyszek MA, Shay JW and Gazdar AF . (1997). Cancer Res., 57, 2373–2377.

Download references

Acknowledgements

This work was supported in part by Grant DAMD17-01-1-0689-1 from the Department of Defense and Grants PO1 CA91844, P30 CA16620, and U01 CA 86390 from the National Cancer Institute, USA. We thank Stephanis Deming for editing the manuscript and patient population identified through a search of the tumor registry database maintained by the Department of Medical Informatics.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Mao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, L., Soria, JC., Chang, YS. et al. Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer. Oncogene 22, 7123–7129 (2003). https://doi.org/10.1038/sj.onc.1206852

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206852

Keywords

This article is cited by

Search

Quick links